从2026年开始,美国癌症登记簿将只记录男性、女性或不明身份的性别,由于联邦政策的变化,其他身份也随之下降。 Starting in 2026, U.S. cancer registries will only record sex as male, female, or unknown, dropping other identities due to federal policy changes.

从2026年开始,美国由疾病防治中心和NIH资助的癌症登记机构必须把病人的性别分为男性、女性或未知性别,根据与特朗普时代政策相关的联邦指令,放弃“其他”或“非二进制”等选项。 Starting in 2026, U.S. cancer registries funded by the CDC and NIH must classify patient sex as male, female, or unknown, dropping options like "other" or "non-binary" due to federal directives linked to Trump-era policies. 这一变化影响到所有州和领土,如果性别不是男性或女性,则需要数据标记为未知。 The change, affecting all states and territories, requires data to be marked unknown if sex isn't male or female. 公共卫生专家警告这一转变可能损害数据准确性,特别是变性人和非二元人的数据准确性,有可能掩盖癌症趋势和差异。 Public health experts warn this shift may compromise data accuracy, especially for transgender and non-binary individuals, potentially obscuring cancer trends and disparities. 这些登记册对于跟踪癌症模式和制定政策(例如降低直肠筛查年龄)至关重要,它们可能会失去至关重要的洞察力,削弱解决健康不平等问题的努力。 These registries, critical for tracking cancer patterns and shaping policies—such as lowering colorectal screening age—could lose vital insights, weakening efforts to address health inequities.